Even when used with a prescription, Suboxone may cause drug dependence and withdrawal symptoms at the cessation of use. When recovering opiate users become dependent on Suboxone, they must undergo a second detox in a treatment center that does not use maintenance drugs. There are various types of opiate addiction treatment programs. Suboxone may be an effective recovery tool for some but not for others who require a different mode of treatment.

Risks Associated with Suboxone Abuse

Since Suboxone is typically used to treat drug addiction and not commonly known for abuse, the possible risks of abusing Suboxone are not common knowledge. On its own Suboxone may cause dizziness, impaired thinking and drowsiness. Due to possible interactions it is dangerous to combine Suboxone with other drugs that also cause drowsiness such as alcohol, antidepressants or sedatives. Those suffering from alcoholism or with a history of alcoholism should not use Suboxone unless they first consult with a physician who is familiar with their history. Another risk of Suboxone abuse is overdose. Three possible causes of a lethal Suboxone overdose include increasing Suboxone use without medical approval, injecting Suboxone or combining Suboxone with tranquilizers.

You Can Receive Treatment for Suboxone Addiction

If you used Suboxone to overcome opiate addiction and ended up dependent on this replacement drug, you may now feel helpless or feel there is no way to fully recover from opiate dependency. However, help is available and hope for recovery exists. There are treatment facilities that offer Suboxone addiction treatment programs. Through medically supervised detox, individual and group counseling and holistic therapies, you can achieve permanent addiction recovery.

Need Help Finding Suboxone Addiction Treatment?

If you or someone you know may be abusing Suboxone, we can help. Call our toll-free helpline to reach a trusted and knowledgeable counselor who can answer your questions, verify insurance benefits for treatment and recommend recovery options. Our helpline is available 24 hours a day, and all call are confidential. Please call us today, and get the help you need.

Suboxone Side Effects

As with other narcotics, Suboxone is associated with certain side effects with varying degrees of severity. These Suboxone side effects can include the following:

• Allergic reaction
• Slow breathing
• Dizziness or confusion
• Liver problems
• Headache
• Problems sleeping
• Constipation

Suboxone Detoxification and Withdrawal

The withdrawal symptoms associated with Suboxone detox are similar to and can be just as severe as those associated with other highly addictive drugs. While Suboxone is prescribed to treat these symptoms, it can end up causing withdrawal of its own. Once a patient has overcome addiction to another drug with the aid of Suboxone, they typically have to undergo a second detox. The withdrawal symptoms associated with Suboxone detox include the follwoing:

• Yawning
• Sweating
• Nausea
• Vomiting
• Diarrhea
• Pain
• Leg restlessness
• Irritability
• Anxiety
• Cold or flu symptoms
• Insomnia

Suboxone withdrawal symptoms typically peak within 2 days of the last dose and begin to lessen after that, usually all but disappearing after 5 days.

Get Help for Suboxone Addiction Now

If you or a loved one struggles with addiction to Suboxone, you can get help. Call our 24 hour toll-free helpline today. A helpful representative is waiting to assist you in finding a recovery plan that won’t leave you needing another one. Stop the cycle of addiction. Call today.

Suboxone teen abuse

It is not at all surprising therefore that the numbers of teens becoming addicted to opiates has been rising steadily over the last decade. And teens addicted to opiates are at a very high risk to progress to IV administration and at very high risk (higher than for adult users) for HIV or hepatitis infection. Treatment options out there to help address withdrawal symptoms typically are so severe that teenagers end up missing large amounts of class. In order to deal with this particular type of addiction, studies are finding that Suboxone is a more successful counterpart to methadone in teens and generally teens can continue operating with a normal life by taking this medication for their addiction.

Suboxone is a medication containing buprenorphine and naloxone, combined in a single tablet. Buprenorphine-which has been used successfully as a treatment for heroin addiction-works by acting on the brain’s opiate receptors to relieve withdrawal and cravings without prompting the same intense high or dangerous side effects as other opioids. When combined with naloxone, buprenorphine’s abuse potential is further limited because people who try to inject it experience severe withdrawal symptoms. However, when Suboxone is taken orally, as prescribed, these adverse effects do not occur.

Suboxone and Teen Use

Because buprenorphine is a partial agonist for the opioid receptor, patients taking it don’t get high, nor do they experience the lows associated with stopping opioid use. They also experience fewer side effects, such as constipation, than they would with other drugs in this class, such as methadone. Buprenorphone-nalaxone, sold as Suboxone, has been found as the best alternatives for most adolescents, according to the Substance Abuse and Mental Health Services Administration (SAMHSA) experts. In some states teens will need parental consent to receive the medication, but in many states doctors can prescribe this medication without needing parental consent.

Unfortunately, teenage usage of Suboxone has received limited clinical study. One major study has shown that teens on Suboxone do a whole lot better than teens detoxed using clonidine. But that same study showed that although teens did very well while on the Suboxone, most of these teens relapsed at the end of the six-week Suboxone maintenance stage. Experts are calling for more research on how well teens will do when given a very slow tapering down off of the medication. This research led experts to want more research on how teens respond when given a very slow, tapering down off the medication.

Successful Clinical Results

In December 1997, George E. Woody, M.D., gave the results of such a trial before the American Academy of Addiction Psychiatry’s 18th Annual Meeting and Symposium. Dr. Woody was the lead investigator of the “Clinical Trials Network Study of Suboxone-Facilitated Rehabilitation of Opioid-Dependent Adolescents and Young Adults,”conducted at the University of Pennsylvania, Philadelphia. Here is the breakdown of the 152 participants:

• Primary Abuse: 55 percent heroin, 35 percent opiates and analgesics, and ten percent combination of heroin and other opiates
• Ages: 14 to 21 years with a mean age of 19
• Sex: 42 percent were female and 58 percent male
• Longevity of Addiction: Average of two years
• Race: 74 percent white, 25 percent Hispanic, and only three African-American participants
• 19 percent were positive for hepatitis C at baseline, while four participants were seronegative at baseline and positive at 12 weeks (a very high risk situation with major public health implications)
• All participants met the criteria for opioid dependence and tested negative for urine benzoidazepine and methadone.

Suboxone and other methods to Detox

Despite high success for the use of Suboxone to treat opioid abuse, there are still other factors involved, even with teens that must be looked at in order to ensure success. Detox from opiates cannot solely depend on Suboxone. A user must be willing and able to accurately look at one’s life and deal with the emotional and mental instabilities that drive the addiction in the first place. Counseling and therapy are treatment options that help in the process of treatment. Family and loved ones play a huge role by their support and loyalty in the journey of breaking addiction. It’s vital that they’re support to consistent and committed to the end.

Suboxone Addiction Treatment

If you or someone you know is wants to end Suboxone abuse, we can help. Please call our toll free number at (888) 372-5712. We are available 24 hours a day to answer your questions on Suboxone and treatment.

More About Suboxone Abuse

• What Suboxone Treats
• Suboxone History
• Effects of Suboxone
• Suboxone and Buprenorphine
• Watch this Suboxone addiction video

Opioids, for instance, are commonly prescribed because of their effective analgesic, or pain-relieving, properties. Medications that fall within this class-referred to as prescription narcotics-include morphine (e.g., Kadian, Avinza), codeine, oxycodone (e.g., OxyContin, Percodan, Percocet), and related drugs. Morphine, for example, is often used before and after surgical procedures to alleviate severe pain. Codeine, on the other hand, is often prescribed for mild pain. In addition to their pain-relieving properties, some of these drugs, codeine and diphenoxylate (Lomotil) for example, can be used to relieve coughs and diarrhea.

Unfortunately, these particular types of drugs have a high rate of addictive qualities that, if not closely monitored, can result in abuse.

What Does Suboxone Treat?

Suboxone has been deemed as the opiate cure. It’s being used instead of methadone because of its safer and more convenient means of therapy for an opiate abuser. It’s a form of maintenance therapy for opiate dependence.

The active ingredient in Suboxone is buprenorphine. Buprenorphine is an opioid, which means it is a synthetic or man-made opiate. It is approved by the FDA for use as replacement therapy. It can also be used to detoxify or remove opiate dependence. This is done by substituting the medication for the opiate that is being abused, weaning the medication over a period of time and then discontinuing the medication with a reduction in the severity of withdrawal symptoms. These withdrawal symptoms can then be treated for 7-10 days and naltrexone can be administered orally by injection or pellet after a naloxone (Narcan) challenge.

How is the Suboxone Treatment Administered?

The Suboxone treatment walk-through presents a basic overview of office-based treatment for opioid dependence. Inevitably, the protocols will be adapted to fit the individual needs and strengths of each physician’s practice. The clinical pathway for office-based treatment of opioid dependence with Suboxone can be broken down into six phases:

1. Pretreatment Screening
   The goal of pretreatment screening is to determine whether office-based treatment is the best course of action for a particular patient. Pretreatment screening usually consists of a brief interview conducted either over the phone or in person. Patients who are accepted for treatment (ie, whose needs are suited to an office-based treatment regimen) are scheduled for their intake. (Physicians may prefer to perform intake and induction during the same visit.)

   Through a series of forms, pretreatment paperwork is helpful for treatment to proceed for everyone: Completed forms facilitate prompt care, while the patient handouts are a convenient reference tool and help to manage treatment expectations and adherence.

2. Intake
   The primary objective of the intake is to establish a medical record of a patient’s suitability for office-based treatment of opioid dependence. To this end, the intake should document the following:
   • Opioid dependence (through a comprehensive substance dependence assessment)

   • Absence of any significant untreated psychiatric conditions that might interfere with treatment (through a basic mental status evaluation)
   • Presence of psychiatric co-morbidity should not exclude patients from Suboxone treatment. Untreated or inadequately treated psychiatric disorders can interfere with the effective treatment of substance abuse. Alternatively, substance abuse can mimic, exacerbate, or precipitate psychiatric symptoms and disorders. Assessment is fundamental to determining whether symptoms reflect primary psychiatric disorder or substance-induced condition.

   The intake is also a good time to discuss the pros and cons of Suboxone treatment, patients’ treatment expectations, and any other issues or questions related to treatment.

3. Induction
   The goal of induction is to safely suppress opioid withdrawal as rapidly as possible with adequate doses of Suboxone. When a patient’s first induction visit is scheduled, it is important to remember that mild-to-moderate opioid withdrawal symptoms will occur. (otherwise, treatment may have to be postponed). The induction phase usually averages two to five days. To avoid any possible delay of treatment, physicians frequently begin induction immediately following the intake, rather than scheduling the induction for a separate visit.
4. Induction dosing
   Suboxone should be dosed to levels that produce the desired clinical effect: suppressing the withdrawal symptoms and cravings that trigger opioid use. Under-dosing during induction does not offer any clinical benefits. In fact, under-dosing may actually increase the risk of treatment failure because it fails to adequately control patients’ withdrawal symptoms and cravings. Patients whose symptoms and cravings are not suppressed may try to self-medicate with opioids or other substances. Patients who test positive for supplemental drug use may need their Suboxone dose titrated upward.

   When considering the safety of higher doses during induction, physicians should be aware that Suboxone can reduce respiratory rate. However, because buprenorphine is a partial opioid agonist, when taken alone it exhibits a “ceiling effect” on respiratory depression—unlike full opioid agonists with which respiratory depression continues increasing as the dose increases. This “ceiling effect” means Suboxone by itself is unlikely to cause death in the event of an overdose.

5. Upon leaving the office
   Some physicians prefer to prescribe enough Suboxone so that patients can take additional doses at home as needed. In such instances, physicians may ask patients to document their withdrawal symptoms and Suboxone.
6. Stabilization
   Induction is completed when the patient:
   • Experiences no withdrawal symptoms
   • Experiences minimal to no side effects
   • Has no uncontrollable cravings for opioids
   • Is not using additional opioids

   During the next phase, stabilization, the patient’s Suboxone dose is “fine-tuned.” The objective is to find the minimum dose necessary to hold the patient in treatment, suppress opioid withdrawal effects, and suppress other opioid use (this dose can be anywhere from 4 to 24 mg per day, depending on the individual).

   Psychosocial counseling usually begins during stabilization. The length of the stabilization phase will vary depending on the needs of the patient. Some patients elect to proceed directly from stabilization to medically supervised withdrawal. However, unless there is a compelling reason to avoid all opioid use, longer-term buprenorphine treatment (ie, maintenance) is usually recommended because of the higher likelihood for treatment success.

7. Maintenance
   The goals of the maintenance phase are:
   • Preventing opioid withdrawal symptoms
   • Suppressing opioid cravings
   • To greatly attenuate the use of self-administered opioids
   • To have Suboxone therapy and psychosocial counseling continue. Treatment compliance and progress are regularly monitored and may entail urine screening tests and other laboratory evaluations as appropriate.

   As the patient moves further along in treatment and their condition improves, the need for frequent monitoring generally abates. The duration of the maintenance phase depends on the individual needs of the patient and can range from weeks to years.

Suboxone Addition Help

If you or someone you know is struggling with a suboxone/opiate addiction and needs to quit Suboxone abuse, we can help. Please call our toll free number at (888) 371-5712. We are available 24 hours a day to answer your questions on suboxone/opiate addiction and treatment.
More About Suboxone Abuse

• Teen Suboxone Use
• Suboxone History
• Effects of Suboxone
• Suboxone and Buprenorphine
• Watch this Suboxone addiction video

From Methadone to Suboxone

President Nixon formed the Drug Enforcement Administration (DEA) in 1973 – the same year The Methadone Control Act was introduced. For about 10 years prior, physicians could prescribe methadone which was discovered to help addicted patients stay off heroin and other opioids.

A person addicted to heroin must inject about every four to six hours to prevent withdrawal. Some users would run out of money and commit crimes to support their addiction. Methadone, a synthetic opioid, allowed for 24 hour dosing. Doctors saw this as life-saving and crime reducing. Then the Methadone Control Act was introduced and limited doctors from this practice.

Some say it was a way for the Nixon Administration to somehow take credit for the doctor’s discovery of treating addicted patients with methadone. The Act imposed conditions requiring patients to go to a clinic for dispensing of methadone daily. They could no longer get a prescription from their doctor, but instead forced together with other addicted people to get treated at the same place and at about the same time. No thought was given to the implications of connecting thousands of people with addictions with each other or requiring daily trips to get medication. No other disease in history had been subjected to such a system nor has any since.

Recognition of the urgent public health need for opioid-dependence treatment alternatives was one of the reasons Suboxone was developed in cooperation with the National Institute of Drug Abuse.

What is Suboxone and how was it Developed?

In 2001, opioid dependence accounted for 18 percent of all substance abuse treatment admissions, exceeding cocaine admissions for the 5th consecutive year. At present, the number of untreated opioid-dependent patients in the United States is believed to be at least 1.2 million.

The primary ingredient in Suboxone is buprenorphine which is a semi-synthetic opiate with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as sublingual tablets, and as an injectable formulation. In 2000, Congress approved the Drug Addiction Treatment Act (DATA 2000), giving physicians the right to use approved opioids to treat opioid dependence in their offices. Prior to DATA 2000, this was illegal to do outside a hospital or clinic.

Use of Suboxone Worldwide

In October 2002, the US Food and Drug Administration (FDA) approved Suboxone and Subutex, buprenorphine’s high-dose sublingual pill preparations for opioid addiction, and as such the drug is now also used for this purpose. France approved buprenorphine for the treatment of opioid dependence in 1996. Australia followed in 2001.

Now approved in more than 30 countries, buprenorphine is marketed in the United States under the brand names Suboxone and Subutex (buprenorphine HCl sublingual tablets).

In the European Union, Suboxone and Subutex, buprenorphine’s high-dose sublingual pill preparations were approved for opioid addiction treatment in September 2006. In the Netherlands, buprenorphine is a List II drug of the Opium Law, though special rules and guidelines apply to its prescription and dispensation. In the USA, it has been a Schedule III drug under the United Nations’ Convention on Psychotropic Substances since it was rescheduled from Schedule V just before FDA approval of Suboxone and Subutex. In recent years, buprenorphine has been introduced in most European countries as a transdermal formulation for the treatment of chronic pain.

Get Help for Suboxone Addiction

If you or someone you know is struggling with a Suboxone/opiate addiction and wants to stop Suboxone use, we can help. Please call our toll free number at (888) 371-5712. We are available 24 hours.
More About Suboxone Abuse

• Teen Suboxone Use
• What Suboxone Treats
• Effects of Suboxone
• Suboxone and Buprenorphine
• Watch this Suboxone abuse video

Suboxone Withdrawal Effects

Someone who has been taking Suboxone for an extended period of time and decides to quit cold turkey will experience withdrawal effects. It is important to contact a rehab facility in order to come off the drug in a safe environment and not experience severe withdrawal effects. When addicted to a drug like Suboxone, it is important to gradually reduce the amount over time. Some earlier withdrawal effects are:

Suboxone abuse can cause headaches, anxiety and nausea.

• Agitation
• Anxiety
• Muscle aches
• Increased tearing
• Insomnia
• Running nose
• Sweating
• Yawning

Later effects are:

• Abdominal cramping
• Diarrhea
• Dilated pupils
• Goose bumps
• Nausea
• Vomiting

Suboxone Side Effects

Be careful while operating heavy machinery or driving because Suboxone may increase drowsiness, dizziness or impaired thinking. It is also dangerous to mix Suboxone with alcohol because it may increase the drowsiness and dizziness. Some side effects are less serious. Do not stop taking the medication but contact your doctor if you are experiencing any of these effects:

• Headache
• Pain
• Problem sleeping
• Nausea
• Sweating
• Stomach pain
• Constipation

Other side effects are more serious. Discontinue use and contact your doctor immediately if you are experiencing any of these effects:

• An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue or face; or hives)
• Slow breathing
• Dizziness
• Confusion
• Liver problems (yellowing of the skin or eyes, dark colored urine, light colored stools, prolonged decreased appetite, nausea, or lower stomach pains)

Suboxone Facts

Suboxone is an approved opioid medication which aids in the treatment of opiate addictions. It contains a combination of buprenorphine and naloxone. Buprenorphine is an opioid medication that is similar to other opioids (morphine, codeine, heroin). However, it produces a less euphoric effect, which makes it easier to discontinue use. Buprenorphine is a partial opioid agonist, which means its effects are limited compared to drugs like oxycodone or heroin because they are full opioid agonists.

Suboxone also contains naloxone; which is an opioid antagonist. The naloxone is used to discourage users from abusing Suboxone. If injected, the naloxone will reach the bloodstream and cause the user to almost immediately go into withdrawal. However, when Suboxone is placed under the tongue (as directed), very little naloxone reaches the bloodstream. Therefore, the patient only feels the effects of buprenorphine. Suboxone is beneficial to the patient because it reduces opioid use and helps patients stay in treatment by suppressing symptoms of opioid withdrawal and decreases cravings for opioids. Suboxone is a highly dependent drug; therefore, withdrawal symptoms may occur if you stop taking the medication too quickly.

Side Effects in Conjunction with Other Drugs

When taken in excess, the risk of respiratory depression increases and can be dangerous if taken in conjunction with alcohol, sedatives, tranquilizers and any other form of CNS depressant medication. The risks of overdose are low, however, but nonetheless, levels of intake should be monitored and adhered to.

With that being said, Suboxone should not be taken in conjunction with the following medications. Drowsiness also increases when taken in partnership with any of these other drugs.

• Antidepressants
• Alcohol
• Antihistamines
• Sedatives (for insomnia)
• Other pain relievers
• Anxiety medicines
• Muscle relaxants

Sensitivity Effects

Hypersensitivity to the nalexone in the medication has been reported by patients in very rare occasions. Normally, if nalexone is taken alone, this medication has no effect on these patients. However for those who do incur a reaction, a severe withdrawal period takes place. But this happens on very rare occasion.

Other Effects

In addition to physical side effects of taking Suboxone, many patients have reported other consequences and adverse effects. Through habitual and progressive use, the tolls on one’s mind affect relationships of all magnitudes. Other indicators of dependency on Suboxone include:

• Loss of enjoyment for simple things in life
• Indifference toward family activities and loved ones
• Decreased interest in sex and affection
• Loss of professional drive and personal ambition
• Ignorance of how instability affects others than self
• Additional signs of clinical depression, including:
  • Irritability, anger
  • Self-criticism, sadness, or emptiness
  • Loss of appetite
  • Loss of restful sleep
  • Impaired libido, impotence

Suboxone Abuse Help

If you or someone you know is suffering from an addiction to Suboxone and needs to stop Suboxone addiction, please call our toll free number at (888) 371-5712. Someone is available 24 hours a day to help you with treatment options.
More About Suboxone Abuse

• Teen Suboxone Use
• What Suboxone Treats
• Suboxone History
• Suboxone and Buprenorphine
• Watch this Suboxone abuse video

Suboxone also contains naloxone; which is an opioid antagonist. The naloxone is used to discourage users from abusing Suboxone. If injected, the naloxone will reach the bloodstream and cause the user to almost immediately go into withdrawal. However, when Suboxone is placed under the tongue (as directed), very little naloxone reaches the bloodstream. Therefore, the patient only feels the effects of buprenorphine.

Suboxone is beneficial to the patient because it reduces opioid use and helps patients stay in treatment by suppressing symptoms of opioid withdrawal and decreases cravings for opioids. Suboxone is a highly dependent drug; therefore, withdrawal symptoms may occur if you stop taking the medication too quickly.

Buprenorphine

The Drug Addiction Treatment Act of 2000 (DATA 2000) made is possible for physicians to legally treat patients with opioid addictions with the aid of buprenorphine. The SAMHSA Sponsored Buprenorphine Physician Clinical Support System (PCSS) is a network of trained physicians who are trained in buprenorphine and help practicing physicians incorporate buprenorphine into their treatment plans for those who have opioid addictions. Physicians also must agree to refer patients for drug addiction counseling. Physicians prescribing buprenorphine therapy must maintain a log of all patients using Subutex and Suboxone and record the medication that has been prescribed to them. The medical records of these patients are subject to periodic DEA and FDA review.

Certification to prescribe Buprenorphine is composed of more than 1,700 physicians or group practices in the United States. As of now, physicians currently are only allowed to prescribe Suboxone to 30 patients at any given time. The 30-patient limit also applies to group practices. However, Congress is considering the Drug Addiction Treatment Expansion Act of 2003. This legislation, if passed, will amend DATA 2000 by lifting the 30-patient limit imposed on group practices and allowing each physician in a group practice to prescribe buprenorphine to 30 patients.

Buprenorphine alone would be a highly dependent drug because it is an opioid medication similar to many other ones; however, the “high” is not quite as intense as other drugs (heroin and morphine). Within Suboxone, buprenorphine works with the naloxone which discourages abuse because if it is injected into the bloodstream, it causes immediate withdrawal effects.

Initial precautions were set in place before buprenorphine was made available to the public because of widespread pharmaceutical diversion and increased prescription drug abuse in the nation. Suboxone was designed specifically to meet FDA requirements with hopes that it would divert attention away from drug withdrawal in opiate addiction therapy. Further, in 2002 the Drug Enforcement Administration (DEA) reassessed the potential for abuse of, diversion of, and addiction to buprenorphine and rescheduled it from a Schedule V drug to a Schedule III drug, thus increasing the penalties for illegally obtaining, possessing, or abusing buprenorphine.

Buprenorphine Side Effects

Be careful while operating heavy machinery or driving because Suboxone may increase drowsiness, dizziness or impaired thinking. It is also dangerous to mix Suboxone with alcohol because it may increase the drowsiness and dizziness. Some side effects are less serious. Do not stop taking the medication but contact your doctor if you are experiencing any of these effects:

• Headache
• Pain
• Problem sleeping
• Nausea
• Sweating
• Stomach pain
• Constipation

Other side effects are more serious. Discontinue use and contact your doctor immediately if you are experiencing any of these effects:

• An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue or face; or hives)
• Slow breathing
• Dizziness
• Confusion
• Liver problems (yellowing of the skin or eyes, dark colored urine, light colored stools, prolonged decreased appetite, nausea, or lower stomach pains

Effects

Buprenorphine is a derivative of thebaine, an extract of opium. The drug can produce feelings of euphoria, analgesia and sedation, thereby making is an opioid. Buprenorphine produces, however, a lesser degree of these respiratory depressive reactions than full opiate drugs such as heroin and morphine. It therefore does not have a significant impairment on cognitive or motor skills. It’s used to help reduce cravings for heroin and other strong opiates by also weakening the symptoms of withdrawal and assisting individuals of addiction to stop abusing drugs.

Buprenorphine is estimated to be effective for approximately ½ to 2/3 of the opiate abuser population. Thankfully, buprenorphine also has a “ceiling effect” which means that increasing the dosage taken of the drug does not produce increased effects after a certain point, or ceiling. Consequently though, high doses of the drug can actually precipitate withdrawal symptoms in opiate addicted individuals. Because of this ceiling effect, buprenorphine is less susceptible to abuse than other opiates. However, high doses of the drug can cause withdrawal symptoms.

Buprenorphine Addiction Help

If you or a loved one is addicted to Suboxone and wants to stop Suboxone abuse, it is important to seek help. Suboxone is a highly dependent drug. Once addicted, the effects are devastating. But, there is hope. If you are interested in receiving information on Suboxone detox or rehab, please call our toll free number at (888) 371-5712.
More About Suboxone Abuse

• Teen Suboxone Use
• What Suboxone Treats
• Suboxone History
• Effects of Suboxone
• Watch this Suboxone addiction video